Breast Cancer Drug Declared 'Too Expensive' for NHS

The video discusses the impact of the drug Kadcyla on a breast cancer patient, highlighting its effectiveness but also its high cost, which limits accessibility on the NHS. It compares international drug policies, noting that some countries have adopted Kadcyla while the UK has not. Legal and advocacy efforts are explored, emphasizing the need for better patient access to new treatments. The video concludes with a call for collaboration among health authorities to improve drug availability.

What new insight or understanding did you gain from this video?